Enantiomer-specific effects of albuterol on airway inflammation in healthy and asthmatic cats

International Archives of Allergy and Immunology

Volumn 150, Issue 1, 2009, Pages 43-50

  Reinero, Carol R ^a   Delgado, Cherlene ^a   Spinka, Christine ^b   DeClue, Amy E ^a   Dhand, Rajiv ^c,d  

^a UNIVERSITY OF MISSOURI   (United States)

^b School of Medicine ^*  (United States)

^c School of Medicine   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cat; Inhalation; R Albuterol; S Albuterol

Indexed keywords

LEVALBUTEROL; PLACEBO; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATATION; CAT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG MIXTURE; ENANTIOMER; FEMALE; IN VIVO STUDY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RESPIRATORY TRACT DISEASE;

ALBUTEROL; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; CATS; CYTOKINES; MALE; PNEUMONIA; STEREOISOMERISM;

EID: 63349099048     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210379     Document Type: Article

References (35)

1. Cherry D, Burt C, Woodwell D: National ambulatory medical care survey: 2001 Summary. Adv Data 2003; 337: 1-44.
2. D'Alonzo G: Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease. JAOA 2004; 104: 288-293. (Pubitemid 38944268)
3. Cho S, Hartleroad J, Oh C: (S)- Albuterol increases the production of histamine and IL-4 in mast cells. Int Arch Allergy Immunol 2001; 124: 478-484. (Pubitemid 32429691)
4. Baramki D, Koester J, Anderson A, Borish L: Modulation of T-cell function by (R)- and (S)- isomers of albuterol: anti-inflammatory influences of (R)- isomers are negated in the presence of the (S)- isomer. J Allergy Clin Immunol 2002; 109: 449-454. (Pubitemid 34234195)
5. Agrawal DK, Ariyarathna K, Kelbe P: (S)-Albuterol activates pro-constrictory and proinflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol 2004; 113: 503-510. (Pubitemid 38338957)
6. Mitra S, Ugur M, Ugur O, Goodman H, McCullough J, Yamaguchi H : (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998; 53: 347-354. (Pubitemid 28162854)
7. Volcheck G, Kelkar P, Bartemes K, Gleich G, Kita H: Effects of (R)- and (S)- isomers of β-adrenergic agonists on eosinophil response to interleukin-5. Clin Exp Allergy 2005; 35:1341-1346. (Pubitemid 43919828)
8. Henderson W, Banerjee E, Chi E: Differential effects of (S)- and (R)- enantiomers of albuterol in a mouse asthma model. J Allergy Clin Immunol 2005; 116: 332-340. (Pubitemid 41096540)
9. Eaton E, Walle U, Wilson H, Aberg G, Walle T: Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br J Clin Pharmacol 1996; 41: 201-206. (Pubitemid 26079181)
10. Dhand R, Goode M, Reid R, Fink J, Fahey P, Tobin M: Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol. Am J Repir Crit Care Med 1999; 160: 1136-1141. (Pubitemid 29487451)
11. Canning B: Modeling asthma and COPD in animals: a pointless exercise? Curr Opin Pharmacol 2003; 3: 244-250.
12. Barnes P: Treatment with (R)-albuterol has no advantage over racemic albuterol. Am J Resp Crit Care Med 2006; 174: 969-972.
13. Qureshi F, Zaritsky A, Welch C, Meadows T, Burke B: Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med 2005; 46: 29-36. (Pubitemid 40916893)
14. Sjöswärd K, Hmani M, Davidsson A, Söderkvist P, Schmekel B: Single-isomer R-salbutamol is not superior to racemate regarding protection for bronchial hyperresponsiveness. Respir Med 2004; 98: 990-999. (Pubitemid 40036592)
15. Hardasmalani M, DeBari V, Bithoney W, Gold N: Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. Pediatr Emerg Care 2005; 21:415-419. (Pubitemid 41061549)
16. Moise N, Wiedenkeller D, Yeager A: Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). J Am Vet Med Assoc 1989; 194: 1467-1473.
17. Howard E, Ryan C: Chronic obstructive pulmonary disease in the domestic cat. Calif Vet 1982; 6: 7-11.
18. Dye J, McKiernan B, Rozanski E, Hoffmann W: Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. J Vet Intern Med 1996; 10: 385-400. (Pubitemid 126701158)
19. Norris Reinero C, Decile K, Berghaus R, Williams K, Leutenegger C, Walby W, Schelegle E, Hyde D, Gershwin L: An experimental model of allergic asthma in cats sensitized to house dust mite or Bermuda grass allergen. Int Arch Allergy Immunol 2004; 135: 117-131. (Pubitemid 39370421)
20. Dhand R, Berghaus R, Gershwin L, Reinero C: Does nebulized racemic albuterol provoke airway inflammation in cats? Proc Am Thoracic Soc 2005; 2:A357.
21. Waldrep J, Berlinski A, Dhand R: Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer. J Aerosol Med 2007; 20:310-319. (Pubitemid 47463184)
22. Reinero C, Cohn L, Delgado C, Spinka C, Schooley E, DeClue A: Adjuvanted rush immunotherapy using CpG oligodeoxy nucleotides in experimental feline allergic asthma. Vet Immunol Immunopath 2008; 121: 241-250. (Pubitemid 351163398)
23. Westerhof F, Zuidhof A, Kok L, Meurs H, Zaagsma J: Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity. Eur Respir J 2005; 25: 864-872. (Pubitemid 40667685)
24. Frohock J, Wijkstrom-Frei C, Salathe M: Effects of albuterol enantiomers on ciliary beat frequency in ovine tracheal epithelial cells. J Appl Physiol 2002; 92: 2396-2402. (Pubitemid 34666364)
25. Ibe B, Portugal A, Raj J: Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma. Int Arch Allergy Immunol 2006; 139: 225-236. (Pubitemid 43289507)
26. Jalba MS: Three generations of ongoing controversies concerning the use of short acting beta-agonist therapy in asthma. J Asthma 2008; 45: 9-18.
27. Gumbhir-Shah K, Kellerman D, DeGraw S, Koch P, Jusko W: Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers. J Clin Pharmacol 1998; 38: 1096-1106. (Pubitemid 29046592)
28. Schmekel B, Rydberg I, Norlander B, Sjöswärd K, Ahlner J, Andersson R: Stereoselective pharmacokinetics of S-salbutamol after administration of racemate in healthy volunteers. Eur Respir J 1999; 13: 1230-1235. (Pubitemid 29357136)
29. Ward J, Dow J, Dallow N, Enynott P, Milleri S, Ventresca G: Enantiomeric disposition of inhaled, intravenous and oral racemic-salbutamol in man - no evidence of enantioselective lung metabolism. Br J Clin Pharmacol 2000; 49: 15-22. (Pubitemid 30050482)
30. Lipworth B, Clark D, Koch P, Arbeeny C: Pharmacokinetics and extrapulmonary β2-adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers. Thorax 1997; 52: 849-852 (Pubitemid 27473925)
31. Jacobson G, Chong F, Baker R: (R,S)-Salbutamol plasma concentrations in severe asthma. J Clin Pharm Ther 2003; 28: 235-238. (Pubitemid 36783100)
32. Gauvreau G, Jordana M, Watson R, Cockcroft D, O'Byrne P: Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med 1997; 156: 1738-1745. (Pubitemid 28011776)
33. Swystun V, Gordon J, Davis B, Zhang X, Cockcroft D: Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000; 106: 57-64. (Pubitemid 30482853)
34. Gordon J, Swystun V, Li F, Zhang X, Davis B, Hull P, Cockcroft D: Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J 2003; 22: 118-126. (Pubitemid 36896481)
35. Cockcroft D, Swystun V: Effect of single doses of S-salbutamol, R-salbutamol, recemic salbutamol, and placebo on the airway response to methacholine. Thorax 1997; 52: 845-848. (Pubitemid 27473924)